Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,752 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Molecular dissection of TDP-43 proteinopathies.
Hasegawa M, Nonaka T, Tsuji H, Tamaoka A, Yamashita M, Kametani F, Yoshida M, Arai T, Akiyama H. Hasegawa M, et al. Among authors: yamashita m. J Mol Neurosci. 2011 Nov;45(3):480-5. doi: 10.1007/s12031-011-9571-x. Epub 2011 Jun 16. J Mol Neurosci. 2011. PMID: 21678031
[Molecular dissection of TDP-43 in ALS and FTLD].
Hasegawa M, Arai T, Nonaka T, Tsuji H, Yamashita M, Hosokawa M, Kametani F, Tamaoka A, Akiyama H. Hasegawa M, et al. Among authors: yamashita m. Rinsho Shinkeigaku. 2010 Nov;50(11):937-9. doi: 10.5692/clinicalneurol.50.937. Rinsho Shinkeigaku. 2010. PMID: 21921518 Japanese.
Epitope mapping of antibodies against TDP-43 and detection of protease-resistant fragments of pathological TDP-43 in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
Tsuji H, Nonaka T, Yamashita M, Masuda-Suzukake M, Kametani F, Akiyama H, Mann DM, Tamaoka A, Hasegawa M. Tsuji H, et al. Among authors: yamashita m. Biochem Biophys Res Commun. 2012 Jan 6;417(1):116-21. doi: 10.1016/j.bbrc.2011.11.066. Epub 2011 Nov 22. Biochem Biophys Res Commun. 2012. PMID: 22133678
Molecular analysis and biochemical classification of TDP-43 proteinopathy.
Tsuji H, Arai T, Kametani F, Nonaka T, Yamashita M, Suzukake M, Hosokawa M, Yoshida M, Hatsuta H, Takao M, Saito Y, Murayama S, Akiyama H, Hasegawa M, Mann DM, Tamaoka A. Tsuji H, et al. Among authors: yamashita m. Brain. 2012 Nov;135(Pt 11):3380-91. doi: 10.1093/brain/aws230. Epub 2012 Oct 3. Brain. 2012. PMID: 23035040
Distinct pathways leading to TDP-43-induced cellular dysfunctions.
Yamashita M, Nonaka T, Hirai S, Miwa A, Okado H, Arai T, Hosokawa M, Akiyama H, Hasegawa M. Yamashita M, et al. Hum Mol Genet. 2014 Aug 15;23(16):4345-56. doi: 10.1093/hmg/ddu152. Epub 2014 Apr 3. Hum Mol Genet. 2014. PMID: 24698978
Methylene blue and dimebon inhibit aggregation of TDP-43 in cellular models.
Yamashita M, Nonaka T, Arai T, Kametani F, Buchman VL, Ninkina N, Bachurin SO, Akiyama H, Goedert M, Hasegawa M. Yamashita M, et al. FEBS Lett. 2009 Jul 21;583(14):2419-24. doi: 10.1016/j.febslet.2009.06.042. Epub 2009 Jun 26. FEBS Lett. 2009. PMID: 19560462 Free article.
[TDP-43 proteinopathies, toward understanding of the molecular pathogenesis].
Hasegawa M, Nonaka T, Yamashita M, Kametani F, Arai T, Yoshida M, Hashizume Y, Tsuchiya K, Akiyama H. Hasegawa M, et al. Among authors: yamashita m. Rinsho Shinkeigaku. 2009 Nov;49(11):783-5. doi: 10.5692/clinicalneurol.49.783. Rinsho Shinkeigaku. 2009. PMID: 20030209 Review. Japanese.
Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy.
Arai T, Hasegawa M, Nonoka T, Kametani F, Yamashita M, Hosokawa M, Niizato K, Tsuchiya K, Kobayashi Z, Ikeda K, Yoshida M, Onaya M, Fujishiro H, Akiyama H. Arai T, et al. Among authors: yamashita m. Neuropathology. 2010 Apr;30(2):170-81. doi: 10.1111/j.1440-1789.2009.01089.x. Epub 2010 Jan 19. Neuropathology. 2010. PMID: 20102522 Review.
3,752 results